Rotate to portrait

Vizual Stocks works best vertically on mobile.

VizualStocks API
PUBLIC DATA DEFINITIONS

GE HealthCare Technologies KPI & segment coverage

Operating KPI and segment definitions available for GE HealthCare Technologies (GEHC) through the VizualStocks API.

GEHC20 metric seriesCatalog checked 2026-10-28

Active metrics 16

SEGMENT

Advanced Imaging Solutions EBIT

Period profit from medical imaging equipment, ultrasound, image-guided procedures, and associated software and services in GE HealthCare's Advanced Imaging Solutions reportable segment. Segment EBIT excludes interest, non-operating benefit costs, restructuring, acquisition and disposition items, separation costs, acquired-intangible amortization and investment revaluations under GE HealthCare's definition.

advancedImagingSolutionsEbit
Frequency
quarterly / annual
Reported history
Q1'24 — Q2'26
History endpoint
SEGMENT

Advanced Imaging Solutions Revenue

Period revenue from medical imaging equipment, ultrasound, image-guided procedures, and associated software and services in GE HealthCare's Advanced Imaging Solutions reportable segment. The current segment was created by combining Imaging and Advanced Visualization Solutions in Q2 2026, with issuer-recast history from 2024.

advancedImagingSolutionsRevenue
Frequency
quarterly / annual
Reported history
Q1'24 — Q2'26
History endpoint
COMPANY KPI

Backlog

Estimated period-end revenue from GE HealthCare customer contracts that are partially or fully unperformed, including deferred contract liabilities, cancellable contracts and lease contracts. Its scope is broader than remaining performance obligations, which exclude certain cancellable contracts.

backlog
Frequency
quarterly / annual
Reported history
Q4'25 — Q2'26
History endpoint
COMPANY KPI

Book To Bill

GE HealthCare contractual customer orders for specified goods and services at an agreed price divided by total revenue for the same quarter or full year.

bookToBill
Frequency
quarterly / annual
Reported history
Q4'22 — Q2'26
History endpoint
SEGMENT

China Region Revenue

Revenue from products and services sold in GE HealthCare's China reporting region, including China, Taiwan, Mongolia and Hong Kong. It differs from the China-only country disclosure.

chinaRegionRevenue
Frequency
quarterly / annual
Reported history
Q2'21 — Q2'26
History endpoint
SEGMENT

Emea Revenue

Revenue from products and services sold in GE HealthCare's Europe, Middle East and Africa reporting region.

emeaRevenue
Frequency
quarterly / annual
Reported history
Q2'21 — Q2'26
History endpoint
SEGMENT

Health Care Financial Services Revenue

Period revenue from GE HealthCare Financial Services, which the issuer presents as Other outside its reportable segments. This disclosed financing business revenue completes the segment revenue reconciliation.

healthCareFinancialServicesRevenue
Frequency
quarterly / annual
Reported history
Q3'21 — Q2'26
History endpoint
COMPANY KPI

Organic Orders Growth

Year-over-year growth in GE HealthCare contractual customer orders, excluding recent acquisitions and dispositions with less than a full comparable year and foreign-exchange fluctuations. Values are percentage points of growth on a constant-currency basis.

organicOrdersGrowth
Frequency
quarterly / annual
Reported history
Q1'22 — Q2'26
History endpoint
SEGMENT

Patient Care Solutions EBIT

Period profit from patient monitoring, anesthesia, respiratory care and maternal-infant care products and related services in GE HealthCare's Patient Care Solutions reportable segment. Segment EBIT excludes interest, non-operating benefit costs, restructuring, acquisition and disposition items, separation costs, acquired-intangible amortization and investment revaluations under GE HealthCare's definition.

patientCareSolutionsEbit
Frequency
quarterly / annual
Reported history
Q2'21 — Q2'26
History endpoint
SEGMENT

Patient Care Solutions Revenue

Period revenue from patient monitoring, anesthesia, respiratory care and maternal-infant care products and related services in GE HealthCare's Patient Care Solutions reportable segment.

patientCareSolutionsRevenue
Frequency
quarterly / annual
Reported history
Q2'21 — Q2'26
History endpoint
SEGMENT

Pharmaceutical Diagnostics EBIT

Period profit from contrast media and radiopharmaceutical agents used in diagnostic imaging in GE HealthCare's Pharmaceutical Diagnostics reportable segment. Segment EBIT excludes interest, non-operating benefit costs, restructuring, acquisition and disposition items, separation costs, acquired-intangible amortization and investment revaluations under GE HealthCare's definition.

pharmaceuticalDiagnosticsEbit
Frequency
quarterly / annual
Reported history
Q2'21 — Q2'26
History endpoint
SEGMENT

Pharmaceutical Diagnostics Revenue

Period revenue from contrast media and radiopharmaceutical agents used in diagnostic imaging in GE HealthCare's Pharmaceutical Diagnostics reportable segment.

pharmaceuticalDiagnosticsRevenue
Frequency
quarterly / annual
Reported history
Q1'21 — Q2'26
History endpoint
SEGMENT

Product Revenue

Period sales of GE HealthCare medical equipment, pharmaceutical diagnostic agents, software licenses excluding hosting and SaaS, and options and upgrades. This is the product component of the issuer's product-versus-service revenue disaggregation across businesses.

productRevenue
Frequency
quarterly / annual
Reported history
Q2'21 — Q2'26
History endpoint
SEGMENT

Rest Of World Revenue

Revenue from products and services sold in GE HealthCare's reporting region outside United States and Canada, Europe, Middle East and Africa, and the China region.

restOfWorldRevenue
Frequency
quarterly / annual
Reported history
Q2'21 — Q2'26
History endpoint
SEGMENT

Service Revenue

Period revenue from GE HealthCare maintenance and repair services for equipment, training, parts, and software hosting through Software as a Service (SaaS). This is the service component of the issuer's product-versus-service revenue disaggregation across businesses.

serviceRevenue
Frequency
quarterly / annual
Reported history
Q2'21 — Q2'26
History endpoint
SEGMENT

Uscan Revenue

Revenue from products and services sold in GE HealthCare's United States and Canada reporting region. It includes Canada and therefore differs from the United States-only country disclosure.

uscanRevenue
Frequency
quarterly / annual
Reported history
Q2'21 — Q2'26
History endpoint

Discontinued historical metrics 4

SEGMENT

Advanced Visualization Solutions Legacy EBIT

Period profit from ultrasound and image-guided therapy products and related services in the former Advanced Visualization Solutions reportable segment. Segment EBIT excludes interest, non-operating benefit costs, restructuring, acquisition and disposition items, separation costs, acquired-intangible amortization and investment revaluations under GE HealthCare's definition.

advancedVisualizationSolutionsLegacyEbit
Frequency
quarterly / annual
Reported history
Q1'22 — Q1'26
History endpoint
SEGMENT

Advanced Visualization Solutions Legacy Revenue

Period revenue from ultrasound and image-guided therapy products and related services in the former Advanced Visualization Solutions reportable segment. Historical observations use issuer-recast comparisons; Imaging and AVS were combined into Advanced Imaging Solutions in Q2 2026.

advancedVisualizationSolutionsLegacyRevenue
Frequency
quarterly / annual
Reported history
Q1'22 — Q1'26
History endpoint
SEGMENT

Imaging Legacy EBIT

Period profit from radiology imaging equipment and related software and services in the former Imaging reportable segment, excluding Image Guided Therapies on the issuer's recast basis. Segment EBIT excludes interest, non-operating benefit costs, restructuring, acquisition and disposition items, separation costs, acquired-intangible amortization and investment revaluations under GE HealthCare's definition.

imagingLegacyEbit
Frequency
quarterly / annual
Reported history
Q1'22 — Q1'26
History endpoint
SEGMENT

Imaging Legacy Revenue

Period revenue from radiology imaging equipment and related software and services in the former Imaging reportable segment, excluding Image Guided Therapies on the issuer's recast basis. Historical observations use issuer-recast comparisons; Imaging and AVS were combined into Advanced Imaging Solutions in Q2 2026.

imagingLegacyRevenue
Frequency
quarterly / annual
Reported history
Q1'22 — Q1'26
History endpoint